# Oral Fexinidazole Dosing Regimens for the Treatment of Adults With Chronic Indeterminate Chagas Disease

> **NCT03587766** · PHASE2 · COMPLETED · sponsor: **Drugs for Neglected Diseases** · enrollment: 45 (actual)

## Conditions studied

- Chagas' Disease (Chronic) Nos

## Interventions

- **DRUG:** Fexinidazole
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03587766
- **Lead sponsor:** Drugs for Neglected Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-13
- **Primary completion:** 2018-12-19
- **Final completion:** 2019-08-28
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2020-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03587766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03587766, "Oral Fexinidazole Dosing Regimens for the Treatment of Adults With Chronic Indeterminate Chagas Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03587766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*